Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Feb;8(1):78-88.
doi: 10.1002/jcsm.12132. Epub 2016 Aug 26.

Integrated care for geriatric frailty and sarcopenia: a randomized control trial

Affiliations
Randomized Controlled Trial

Integrated care for geriatric frailty and sarcopenia: a randomized control trial

Ding-Cheng Derrick Chan et al. J Cachexia Sarcopenia Muscle. 2017 Feb.

Abstract

Background: Exercise, nutrition, and psychological interventions may all have positive impacts on frailty and sarcopenia. However, it is not known whether an integrated care programme with all three components can be beneficial and the intensity of such programme is also not certain. In this study, we aim to determine the effectiveness of two levels of integrated care on frailty and sarcopenia.

Methods: A randomized control trial was conducted at two community hospitals in Taiwan. Older adults (65-79 years of age, N = 289) who scored ≥1 on the Cardiovascular Health Study Phenotypic Classification of Frailty (CHS_PCF) were enrolled in the trial. Low-level care (LLC) participants received a 2 h education course on frailty, sarcopenia, coping strategy, nutrition, and demonstration of study exercise programme. Educational multimedia material was distributed as reference for home practice with bi-monthly telephone follow-ups on adherences. High-level care (HLC) participants, in addition to LLC instructions, received six sessions of on-site problem solving therapy and 48 exercise sessions within 6 months. Brief nutrition consultation was also provided during the exercise sessions. Primary outcome was improvement of the CHS_PCF by at least one category (from pre-frail to robust, or from frail to pre-frail or robust) from baseline. Secondary outcomes included changes of individual frailty, and sarcopenia indicators. Assessments were done at 3, 6, and 12 months by trained research assistants blinded to randomization status. Intention-to-treat analysis was applied.

Results: Mean age was 71.6 ± 4.3 years, with 53% females. For the entire cohort, improvement of primary outcome was 35% at 3 months, increased to 40% at 6 months, and remained stable at 39% at 12 months. Improvement rates were similar in both groups. Compared with the LLC group, HLC participants had greater improvements in the following indices: energy expenditure of walking, 5 m walking time, dominant hand grip strength, timed-up-and-go-test, and one-leg-stand time - mainly at 6 and 12 month assessments.

Conclusions: The 6 month integrated care improved frailty and sarcopenia status among community-dwelling elders, with high-intensity training yielding greater improvements. Low-level care could be promoted as a basic intervention, while HLC could be reserved for those at high risk and with high motivation.

Keywords: Aged; Effectiveness; Frailty; Randomized control trial; Sarcopenia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study participant flow.
Figure 2
Figure 2
Primary outcome: improvement of cardiovascular health study phenotypical classification of frailty scorea. Footnote aDefined as change from pre‐frail to robust, or from frail to pre‐frail or robust. bTime effect (6 months vs 3 months, and 12 months vs 3 months), after adjusting for treatment and site, by the generalized estimating equations (GEE) model. cIntervention effect, after adjusting for site, time, and treatment‐by‐time interactions, by the generalized estimating equations (GEE) model. HLC: High‐Level Care, LLC: Low‐Level Care.

References

    1. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet 2013;381:752–762. - PMC - PubMed
    1. Cruz‐Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39:412–423. - PMC - PubMed
    1. Cooper C, Dere W, Evans W, Kanis JA, Rizzoli R, Sayer AA, et al. Frailty and sarcopenia: definitions and outcome parameters. Osteoporos Int 2012;23:1839–1848. - PubMed
    1. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56:M146–156. - PubMed
    1. Lee PH, Lee YS, Chan DC. Interventions targeting geriatric frailty: a systemic review. J Clin Gerontol Geriatr 2012;3:47–52.

Publication types

LinkOut - more resources